RNA interference silences the human papillomavirus 6b/11 early gene E7 in vitro and in vivo

X Z Chen1, K J Zhu, Y Xu

  • 1Department of Dermatology, School of Medicine, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou City, China.

Abstract

Insights

RNA interference (RNAi) effectively suppressed human papillomavirus (HPV) E7 gene expression in cell cultures and mouse models. This demonstrates RNAi

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • RNA interference (RNAi) shows therapeutic promise for diseases like cancer and viral infections.
  • Targeting human papillomavirus (HPV) E7 genes is a viable strategy for HPV-related tumors.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of RNAi in managing condyloma acuminatum (CA).

Main Methods:

  • Small interfering (si)RNA duplexes and small-hairpin (sh)RNA-expressing plasmids targeting HPV-6b/11 E7 genes were used.
  • Inoculation was performed in cultured cells and HPV E7 gene-expressing mouse tumor models via cationic liposomes, intratumorally, or intravenously.
  • Efficacy was assessed by measuring E7 mRNA levels using real-time PCR.

Main Results:

  • In vitro, siRNAs and shRNA-expressing plasmids reduced HPV-6b/11 E7 mRNA levels to 20-40% at optimal concentrations and 72 hours.
  • In vivo, three intratumoral injections reduced E7 mRNA expression by 45-50%.
  • Intratumoral delivery demonstrated superior inhibition compared to intravenous administration.

Conclusions:

  • RNAi can specifically modulate HPV-6b/11 E7 gene expression.
  • RNAi presents a potential therapeutic approach for managing condyloma acuminatum.

Related Concept Videos

In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...